References
- World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. 2nd ed., 2012; WHO: Geneva.
- Central Statistical Office Z Ministry of Health Z Tropical Diseases Reasearch Centre, et al. Zambia Demographic and Health Survey 2007. 2009; Macro International: Calverton, MD.
- D Webb. Attitudes to ‘Kaponya Mafumo’: the terminators of pregnancy in urban Zambia. Health Policy and Planning. 15(2): 2000; 186–193.
- RN Likwa, A Biddlecom, H Ball. Abortion statistics in Zambia: ‘A research brief for reproductive health programming, policy and research implications’. Issues Brief (Alan Guttmacher Institute). 3: 2009; 1–4.
- Ministry of Health. Standards and guidelines for reducing unsafe abortion morbidity and mortality in Zambia. 2009; MoH: Lusaka.
- Guttmacher Institute. Making Abortion Services Accessible in the Wake of Legal Reforms: A Framework and Six Case Studies. 2012; Guttmacher Institute: New York.
- RK Sneeringer, DL Billings, B Ganatra. Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: a review of the literature. Journal of Public Health Policy. 33(2): 2012; 218–229. 10.1057/jphp.2012.11.
- A Hyman, K Blanchard, F Coeytaux. Misoprostol in women’s hands: a harm reduction strategy for unsafe abortion. Contraception. 87(2): 2013; 128–130. 10.1016/j.contraception.2012.10.020.
- JN Erdman. Harm reduction, human rights, and access to information on safer abortion. International Journal of Gynecology and Obstetrics. 118(1): 2012; 83–86. 10.1016/j.ijgo.2012.04.002.
- RY Lee, R Moles, B Chaar. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges. Contraception. 2014 Aug 15; 10.1016/j.contraception.2014.08.003. Epub ahead of print.
- H von Hertzen, G Piaggio, NTM Huong. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 369(9577): 2007; 1938–1946.
- H von Hertzen, NT Huong, G Piaggio. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. BJOG. 117(10): 2010; 1186–1196. 10.1111/j.1471-0528.2010.02636.x.
- T Fetters, S Vonthanak, C Picardo. Abortion-related complications in Cambodia. BJOG. 115(8): 2008; 957–967. 10.1111/j.1471-0528.2008.01765.x.
- H Gebreselassie, T Fetters, S Singh. Caring for women with abortion complications in Ethiopia: national estimates and future implications. International Perspectives on Sexual and Reproductive Health. 36(1): 2010; 6–15. 10.1363/ipsrh.36.006.10.
- RK Jewkes, T Gumede, MS Westaway. Why are women still aborting outside designated facilities in metropolitan South Africa?. BJOG. 112(9): 2005; 1236–1242.
- S Singh, T Fetters, H Gebreselassie. The estimated incidence of induced abortion in Ethiopia, 2008. International Perspectives on Sexual and Reproductive Health. 36(1): 2010; 16–25.
- D Lara, K Abuabara, D Grossman. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India. Reproductive Health Matters. 13(26): 2005; 65–74.
- TD Ngo, MH Park, TH Nguyen. Pharmacy workers’ knowledge and provision of abortifacients in Ho Chi Minh City, Vietnam. International Journal of Gynecology and Obstetrics. 117(2): 2012; 187–188. 10.1016/j.ijgo.2011.12.017.